The unadjusted median time to symptom resolution was 10 days in both the intervention and placebo groups.
Montelukast didn’t cut time to COVID symptom relief in clinical trial
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows